These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26064979)

  • 1. Skewed Epigenetics: An Alternative Therapeutic Option for Diabetes Complications.
    Togliatto G; Dentelli P; Brizzi MF
    J Diabetes Res; 2015; 2015():373708. PubMed ID: 26064979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Contribution to the Development and Progression of Vascular Diabetic Complications.
    Rodriguez H; El-Osta A
    Antioxid Redox Signal; 2018 Oct; 29(11):1074-1091. PubMed ID: 29304555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Changes in Diabetes and Cardiovascular Risk.
    Keating ST; Plutzky J; El-Osta A
    Circ Res; 2016 May; 118(11):1706-22. PubMed ID: 27230637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of epigenetic mechanisms in the vascular complications of diabetes.
    Reddy MA; Natarajan R
    Subcell Biochem; 2013; 61():435-54. PubMed ID: 23150262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetics: mechanisms and implications for diabetic complications.
    Cooper ME; El-Osta A
    Circ Res; 2010 Dec; 107(12):1403-13. PubMed ID: 21148447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic phenomena linked to diabetic complications.
    Pirola L; Balcerczyk A; Okabe J; El-Osta A
    Nat Rev Endocrinol; 2010 Dec; 6(12):665-75. PubMed ID: 21045787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics and Cardiovascular Disease in Diabetes.
    Pasquier J; Hoarau-Véchot J; Fakhro K; Rafii A; Abi Khalil C
    Curr Diab Rep; 2015 Dec; 15(12):108. PubMed ID: 26458379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of epigenetics in the pathology of diabetic complications.
    Villeneuve LM; Natarajan R
    Am J Physiol Renal Physiol; 2010 Jul; 299(1):F14-25. PubMed ID: 20462972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic mechanisms in diabetic vascular complications.
    Reddy MA; Natarajan R
    Cardiovasc Res; 2011 Jun; 90(3):421-9. PubMed ID: 21266525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation in diabetic vascular complications.
    Jin J; Wang X; Zhi X; Meng D
    J Mol Endocrinol; 2019 Nov; 63(4):R103-R115. PubMed ID: 31600719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes-induced epigenetic signature in vascular cells.
    Mitić T; Emanueli C
    Endocr Metab Immune Disord Drug Targets; 2012 Jun; 12(2):107-17. PubMed ID: 22236027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemic memories and the epigenetic component of diabetic nephropathy.
    Keating ST; El-Osta A
    Curr Diab Rep; 2013 Aug; 13(4):574-81. PubMed ID: 23639991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic modifications: An important mechanism in diabetic disturbances.
    Rorbach-Dolata A; Kubis A; Piwowar A
    Postepy Hig Med Dosw (Online); 2017 Nov; 71(0):960-974. PubMed ID: 29225202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel insights into DNA methylation and its critical implications in diabetic vascular complications.
    Zheng J; Cheng J; Zhang Q; Xiao X
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28183874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic mechanisms in diabetic complications and metabolic memory.
    Reddy MA; Zhang E; Natarajan R
    Diabetologia; 2015 Mar; 58(3):443-55. PubMed ID: 25481708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic changes and alteration of Fbn1 and Col3A1 gene expression under hyperglycaemic and hyperinsulinaemic conditions.
    Gaikwad AB; Gupta J; Tikoo K
    Biochem J; 2010 Dec; 432(2):333-41. PubMed ID: 20836762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epigenetic landscape in the cardiovascular complications of diabetes.
    Costantino S; Ambrosini S; Paneni F
    J Endocrinol Invest; 2019 May; 42(5):505-511. PubMed ID: 30291588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic basis of diabetic vasculopathy.
    Bhamidipati T; Kumar M; Verma SS; Mohanty SK; Kacar S; Reese D; Martinez MM; Kamocka MM; Dunn KW; Sen CK; Singh K
    Front Endocrinol (Lausanne); 2022; 13():989844. PubMed ID: 36568089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic signatures and vascular risk in type 2 diabetes: a clinical perspective.
    Paneni F; Costantino S; Volpe M; Lüscher TF; Cosentino F
    Atherosclerosis; 2013 Oct; 230(2):191-7. PubMed ID: 24075743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remodeling is at the heart of chromatin: the heartaches of chromatin.
    El-Osta A
    Epigenetics; 2011 Jul; 6(7):884-7. PubMed ID: 21646860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.